Company profile
ERC-Belgium S.A. company profile
Epitopoietic Research Corporation (ERC-Belgium SA) is a clinical stage emerging Biopharmaceutical Company developing a safe, highly effective approach for the treatment of cancer, particularly cancers of the brain. ERC has built a network of leading neuro-oncologists in several countries in the world, among others in the US and Europe to propel its immunotherapies through clinical development and to market. ERC’s regimen of therapeutic vaccines has shown early promise in patients suffering from recurrent Glioblastoma multiforme (GBM), the deadliest of brain cancers.
Business identity
- Contact email
- [email protected]
- Phone number
- +32 81 72 86 10
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2006-01-01, Month
Headquarters
- Headquarters
- Gembloux, Wallonia, Belgium
- Country code
- BE
- Continent
- Europe